Supplementary figure 5 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

Autor:	Wei-Dong Han, Qing-Ming Yang, Su-Xia Li, Yang Liu, Kai-Chao Feng, Yan Zhang, Mei-Xia Chen, Wen-Ying Zhang, Ya-Jing Zhang, Xiang Li, Xiao-Hui Wang, Han-Ren Dai, Ye-Lei Guo, Yao Wang, Zhi-Qiang Wu, Chun-Meng Wang
Rok vydání:	2023
DOI:	10.1158/1078-0432.22466207.v1
Popis:	Clinical response of primary-refractory HL in patients receiving CART-30 cell therapy.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a173385b197c0426dadbd8612a367b5 https://doi.org/10.1158/1078-0432.22466207.v1 Zobrazit plný text záznamu